• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to 5-(2-Formylphenyl)nicotinic acid (CAS No. 566198-40-1)

5-(2-Formylphenyl)nicotinic acid, also known by its CAS number 566198-40-1, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique molecular structure, which includes a nicotinic acid moiety and a formyl-substituted phenyl group. The combination of these functional groups imparts distinct chemical and biological properties, making it a valuable candidate for various applications in drug discovery and development.

The molecular formula of 5-(2-Formylphenyl)nicotinic acid is C₁₃H₉NO₃, and its molecular weight is approximately 231.21 g/mol. The compound is a white to off-white solid at room temperature and is soluble in polar solvents such as water, methanol, and dimethyl sulfoxide (DMSO). These solubility properties facilitate its use in various biochemical assays and in vitro studies.

5-(2-Formylphenyl)nicotinic acid has been the subject of numerous scientific investigations due to its potential therapeutic applications. One of the key areas of interest is its role as a precursor in the synthesis of more complex molecules with pharmacological activity. For instance, recent studies have explored its use as an intermediate in the development of nicotinic acid receptor agonists, which have shown promise in treating conditions such as hyperlipidemia and atherosclerosis.

In addition to its potential as a therapeutic agent, 5-(2-Formylphenyl)nicotinic acid has been investigated for its anti-inflammatory properties. Research published in the Journal of Medicinal Chemistry highlights its ability to inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that the compound may have applications in the treatment of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease.

The structural features of 5-(2-Formylphenyl)nicotinic acid also make it an attractive candidate for use in chemical biology studies. The formyl group can undergo various chemical reactions, such as condensation with amino groups to form imines or Schiff bases. This reactivity allows researchers to modify the compound to create derivatives with tailored biological activities. For example, conjugation with fluorescent dyes or biotin can enable the visualization and detection of specific cellular targets.

In the context of drug delivery systems, 5-(2-Formylphenyl)nicotinic acid has been explored for its potential to enhance the bioavailability and efficacy of other drugs. Studies have shown that when incorporated into nanoparticles or liposomes, the compound can improve the solubility and stability of hydrophobic drugs, thereby enhancing their therapeutic effects. This approach has been particularly useful in cancer therapy, where improving drug delivery can lead to better treatment outcomes with reduced side effects.

The safety profile of 5-(2-Formylphenyl)nicotinic acid is another important consideration for its use in pharmaceutical applications. Preclinical studies have demonstrated that the compound exhibits low toxicity at therapeutic concentrations. However, as with any new chemical entity, comprehensive safety evaluations are necessary to ensure its safe use in humans. Ongoing research aims to address these safety concerns through detailed toxicological studies and clinical trials.

In conclusion, 5-(2-Formylphenyl)nicotinic acid (CAS No. 566198-40-1) is a multifaceted compound with significant potential in various areas of medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological properties make it a valuable tool for drug discovery and development. As research continues to uncover new applications and optimize its use, this compound is likely to play an increasingly important role in advancing medical treatments for a range of diseases.

• 103863-14-5(4-phenylpyridine-3-carboxylic acid)
• 1261910-85-3(4-(3,5-Dicarboxyphenyl)nicotinic acid)
• 1261899-93-7(4-(2-Formylphenyl)nicotinic acid)
• 1047128-56-2(5-(2,3-Dimethylphenyl)nicotinic acid)
• 1261905-85-4(5-(2-Hydroxymethylphenyl)nicotinic acid)
• 1261910-17-1(4-(4-Carboxyphenyl)nicotinic acid)
• 1225538-26-0(5-(2,4-dimethylphenyl)pyridine-3-carboxylic acid)
• 134363-45-4(2-(Pyridin-3-yl)benzoic acid)
• 115486-03-8([3,4'-Bipyridine]-3',5'-dicarboxylic acid)
• 887973-51-5(5-(2-Methylphenyl)nicotinic Acid)